Crown Bioscience annonce un investissement accru dans la transformation numérique avec la nomination d'un nouveau COO

08-07

SAN DIEGO---Crown Bioscience annonce aujourd'hui la nomination de John Gu au poste de COO (Chief Operations Officer). M. Gu sera chargé de promouvoir l'excellence dans les opérations mondiales de CrownBio, en mettant à profit sa grande expertise en matière de transformation numérique pour stimuler la productivité.

Celartics Biopharma's dendritic cell-based vaccine against COVID-19 infection found to efficiently produce viral antigen-specific T lymphocytes

05-22

Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart

Kapsułka (granulka) Lianhua Qingwen zatwierdzona do dodatkowego zastosowania w COVID-19

04-18

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10

Li Yu, Administration of Traditional Chinese Medicine: Traditional Chinese Medicine Lianhua Qingwen Plays an Important Role in Fighting Against COVID-19

03-21